Mulling Bernanke's ...
Health Care: Health Services
Rosetta Genomics Ltd. (ROSG: NASDAQ)
$3.80 -0.04 | -1.04%
06/19/13 - 03:59 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 201.00K | 103.00K | 279.00K | 150.00K |
| Cost of Sales | 258.00K | 324.00K | 200.00K | 339.00K |
| Gross Operating Profit | -57.00K | -221.00K | 79.00K | -189.00K |
| Selling, General, and Administrative Expenses | 6.96M | 5.17M | 8.27M | 8.06M |
| Research & Development | 1.25M | 3.39M | 6.49M | 6.55M |
| Operating Income before D & A (EBITDA) | -8.27M | -8.78M | -14.68M | -14.80M |
| Depreciation & Amortization | 1.82M | 454.00K | 428.00K | 344.00K |
| Interest Income | 39.00K | 12.00K | 1.89M | 132.00K |
| Other Income - Net | -2.15M | 1.40M | -554.00K | 20.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -12.20M | -7.82M | -13.77M | -14.99M |
| Interest Expense | 319.00K | 19.00K | 835.00K | 107.00K |
| Pre-Tax Income | -12.52M | -7.84M | -14.60M | -15.10M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | -387.00K | 0.00 |
| Net Income From Continuing Operations | -10.70M | -7.39M | -14.60M | -14.75M |
| Net Income From Discontinued Operations | 239.00K | -1.44M | -539.00K | -1.75M |
| Net Income From Total Operations | -10.46M | -8.83M | -15.14M | -16.50M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -10.46M | -8.83M | -14.76M | -16.50M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-10.70M | -7.39M | -14.60M | -14.75M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -10.70M | -7.39M | -14.60M | -14.75M |
| Basic EPS from Continuing Ops. | -2.40 | -14.55 | -50.40 | -65.40 |
| Basic EPS from Discontinued Ops. | 0.05 | -2.85 | -1.80 | -7.80 |
| Basic EPS from Total Operations | -2.35 | -17.40 | -52.20 | -73.20 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -2.35 | -17.40 | -52.20 | -73.20 |
| Basic Normalized Net Income/Share | -2.40 | -14.55 | -50.40 | -65.40 |
| EPS fr Continuing Ops. | -2.40 | -14.55 | -50.40 | -65.40 |
| EPS fr Discontinued Ops | 0.05 | -2.85 | -1.80 | -7.80 |
| EPS fr Total Ops. | -2.35 | -17.40 | -52.20 | -73.20 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -2.35 | -17.40 | -52.20 | -73.20 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-2.40 | -14.55 | -50.40 | -65.40 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ROSG
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest ROSG Headlines from TheStreet
- 5 Stocks Under $10 Set to Soar 06.06.13 | 02:06 pm
- 3 Health Care Stocks Under $10 to Watch 06.04.13 | 02:06 pm
- 4 Health Care Stocks Under $10 to Watch 04.02.13 | 02:04 pm
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- 3 Stocks Under $5 Making Big Moves 02.05.13 | 02:02 pm
- 7 Stocks Under $10 Making Large Upside Moves 11.23.12 | 12:11 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 3 Stocks Under $10 Making Big Moves 09.18.12 | 02:09 pm
- 5 Stocks Poised for Breakouts 08.24.12 | 12:08 pm
- 5 Stocks Under $10 Set to Soar 08.09.12 | 12:08 pm
Press Releases for ROSG
- Medicare Administrator Issues Final Local Coverage Determination For Rosetta Cancer Origin Testâ¿¢ - PR Newswire 06.13.13 | 12:06 pm
- Rosetta Genomics Executes Credentialing Agreement With Three Rivers Provider Network - PR Newswire 06.07.13 | 08:06 am
- Rosetta Genomics Announces Acceptance For Publication By Molecular Cancer Of Rosetta Cancer Origin Test Manuscript - PR Newswire 06.06.13 | 08:06 am
- Rosetta Genomics To Increase The Number Of U.S. Sales Territories - PR Newswire 06.04.13 | 08:06 am
- Rosetta Genomics Announces Presence At ASCO 2013 - PR Newswire 05.28.13 | 08:05 am
- Rosetta Genomics To Present At The Jefferies 2013 Healthcare Conference - PR Newswire 05.22.13 | 08:05 am
- Rosetta Genomics Announces Credentialing Agreement With Prime Health Services For MiRview Mets2 - PR Newswire 05.20.13 | 08:05 am
- Rosetta Genomics Receives Full Settlement Payment From Sanra Laboratories - PR Newswire 05.10.13 | 08:05 am
- Rosetta Genomics MicroRNA-based Diagnostic Assays To Be Showcased In An Industry Expert Theater Presentation At ASCO's 2013 Annual Meeting - PR Newswire 05.07.13 | 08:05 am
- Rosetta Genomics Reaches Settlement Agreement With Sanra Laboratories In Connection With Previous Sale Of Parkway Clinical Laboratories - PR Newswire 04.18.13 | 09:04 am
Partner Headlines for ROSG
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- 4 Healthcare Stock Stories Prescribed for Investors - Wall St. Cheat Sheet 04.01.13 | 05:04 am
- Rosetta Genomics Expands Management Team With CMO and CSO - Benzinga 10.11.12 | 09:10 am
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 09.18.12 | 09:09 am
- Healthcare Biz Recap: Amylin in FDA HOT WATER, Rosetta Genomics OFFERS Up Shares - Wall St. Cheat Sheet 06.26.12 | 10:06 am
- Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics - Benzinga 06.01.12 | 01:06 pm
- Rosetta Genomics and 3 NASDAQ Top Percentage Losing Stocks - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Rosetta Genomics and 2 NASDAQ Top Percentage Losers - Wall St. Cheat Sheet 05.29.12 | 09:05 am
